Canadian Journal of Gastroenterology and Hepatology / 2017 / Article / Tab 2

Clinical Study

Maintenance of Remission with Partial Enteral Nutrition Therapy in Pediatric Crohn’s Disease: A Retrospective Study

Table 2

Remission rates and concomitant medication.

CovariatePEN group Control group value

Time between diagnosis and EEN initiation (mo), median (range)2.0 (0–112)
Route of EN administration, (%)
 Oral37/42 (88)
 Nasogastric4/42 (10)
 PEG1/42 (2)
Follow-up time (mo), median 25–75%40 25.5–7963 52–87
Length of remission (mo), median (range)6.0 (0–36)6.0 (range: 0–45)
Concomitant medication, (%)
 Corticosteroids26 (62)35 (78)
 Thiopurines35 (83)30 (67)
 Anti-TNF agents14 (33)10 (22)
 Methotrexate7 (17)2 (4)
 Antibiotics19 (45)19 (42)
Time on PEN without concomitant medication (mo), median (range)0 (0–36)
 023/43 (55%)
 1–613/42 (31%)
 7–122/42 (5%)
 13+4/42 (9%)
Length of remission with PEN alone, without concomitant medication (mo), median (range)0 (0–16)
 025/42 (60%)
 1–614/42 (33%)
 7–122/42 (5%)
 13+1/42 (2%)

mo, months; EEN, exclusive enteral nutrition; PEN, partial enteral nutrition; EN, enteral nutrition; PEG, Percutaneous endoscopic gastrostomy; TNF, tumor necrosis factor. Calculated with Chi-square or Fisher’s exact test for categorical data and independent samples -test for continuous variables. Calculated with Mann–Whitney tests.